All great stuff. It's just such a slow process. Meeting this week, if anything like FDA, you probably get report in about 30 days. I believe MFO agreed to fund something like $2 million a quarter. We will read that in quarterly report about May 11.
I have no idea how much the phase 3 OM will cost.
They did say something about being able to work on a project that was held up due to funding. Oral something I would guess.
The further along we are with these projects, the more we will get upfront or as a buyout.
I suggested to Leo the possibility of selling the company for X price per share with a stub that gives the shareholders a % of the cash flow in the future. I personally think that might be the best option. We can only move at a certain pace with the funding we have. A BP could have unlimited funding and get to the goal line much quicker.
Would you take $2 or $3 a share plus 10-15% of net sales of our drugs. I know I would.